HUTCHMED (China) Ltd (HCM)
D
Pipeline Grade
Drug Pipeline (0 Assets)
No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.
Upcoming Catalysts
| Date | Event | Drug |
|---|---|---|
| 2026-10-01 | Phase1 Readout | — |
| 2026-12-01 | Phase1 Readout | — |
Active Clinical Trials (12)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT07409428 | A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL | PHASE3 | Recruiting | 240 |
| NCT04353375 | HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma | PHASE3 | Recruiting | 235 |
| NCT05522231 | Efficacy and Safety of Fruquintinib in Combination With Sintilimab in Advanced Renal Cell Carcinoma (FRUSICA-2) | PHASE3 | Active Not Recruiting | 265 |
| NCT06387069 | A Study to Evaluate HMPL-306 in Patients With IDH1or IDH2-mutated Acute Myeloid Leukemia | PHASE3 | Recruiting | 316 |
| NCT05535933 | HMPL-523 (Sovleplenib) in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia | PHASE3 | Active Not Recruiting | 111 |
| NCT06361888 | A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and ... | PHASE3 | Recruiting | 502 |
| NCT06584032 | Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer | PHASE3 | Recruiting | 412 |
| NCT07228247 | A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors | PHASE2 | Recruiting | 147 |
| NCT07396584 | HMPL-A580 in Participants With Advanced or Metastatic Solid Tumor | PHASE2 | Recruiting | 186 |
| NCT06601504 | Study of HMPL-760 Plus R-GemOx Versus Placebo Plus R-GemOx in Relapsed/Refractory DLBCL | PHASE2 | Active Not Recruiting | 61 |
| NCT06387082 | A Clinical Study of HMPL-506 in Patients With Hematological Malignancies | PHASE1 | Recruiting | 132 |
| NCT07025018 | Phase I Study of HMPL-306 for the Treatment of Gliomas With IDH1 and/or IDH2 Mutations | PHASE1 | Recruiting | 52 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.